Skip to main content
Funded Studies

Martin Hallbeck, MD, PhD

Associate Professor in the Department of Clinical and Experimental Science at Linköping University

Location: Linköping Sweden

With his research, Professor Hallbeck is a senior neuropathologist who aims to increase the understanding of why cells in the brain become sick and why disease spreads throughout the brain in patients with neurodegenerative diseases such as Alzheimer’s and Parkinson’s disease. The aim is to utilize this knowledge to develop novel therapeutic and diagnostic applications. Recently, the work of Hallbeck’s laboratory has included a breakthrough on how toxic protein aggregates piggyback on normal cellular machinery to spread pathology associated with Parkinson’s disease. Targeting these pathways will open new possibilities for diagnosis and treatment.

Associated Grants

  • Validation of Gap Junction Proteins as a New Therapeutic Target for Impeding the Cell-to-cell Spread of Alpha-synuclein in Parkinson’s Disease and Related Synucleinopathies


  • Connexins as a New Therapeutic Target to Impede Spreading of Alpha-synuclein Pathology


We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.